Inhibition by Tetrahydroquinoline Sulfonamide Derivatives of the Activity of Human 8-Oxoguanine DNA Glycosylase (OGG1) for Several Products of Oxidatively induced DNA Base Lesions. 2021

Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States.

DNA glycosylases involved in the first step of the DNA base excision repair pathway are promising targets in cancer therapy. There is evidence that reduction of their activities may enhance cell killing in malignant tumors. Recently, two tetrahydroquinoline compounds named SU0268 and SU0383 were reported to inhibit OGG1 for the excision of 8-hydroxyguanine. This DNA repair protein is one of the major cellular enzymes responsible for excision of a number of oxidatively induced lesions from DNA. In this work, we used gas chromatography-tandem mass spectrometry with isotope-dilution to measure the excision of not only 8-hydroxyguanine but also that of the other major substrate of OGG1, i.e., 2,6-diamino-4-hydroxy-5-formamidopyrimidine, using genomic DNA with multiple purine- and pyrimidine-derived lesions. The excision of a minor substrate 4,6-diamino-5-formamidopyrimidine was also measured. Both SU0268 and SU0383 efficiently inhibited OGG1 activity for these three lesions, with the former being more potent than the latter. Dependence of inhibition on concentrations of SU0268 and SU0383 from 0.05 μmol/L to 10 μmol/L was also demonstrated. The approach used in this work may be applied to the investigation of OGG1 inhibition by SU0268 and SU0383 and other small molecule inhibitors in further studies including cellular and animal models of disease.

UI MeSH Term Description Entries
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011804 Quinolines
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D045647 DNA Glycosylases A family of DNA repair enzymes that recognize damaged nucleotide bases and remove them by hydrolyzing the N-glycosidic bond that attaches them to the sugar backbone of the DNA molecule. The process called BASE EXCISION REPAIR can be completed by a DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE which excises the remaining RIBOSE sugar from the DNA. DNA N-glycosidase,DNA Glycosylase,Methylpurine DNA Glycosylase,DNA Glycosylase, Methylpurine,DNA N glycosidase,Glycosylase, DNA,Glycosylase, Methylpurine DNA,Glycosylases, DNA
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
April 2018, Redox biology,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
January 2018, DNA repair,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
January 2022, Oxidative medicine and cellular longevity,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
November 1997, Nucleic acids research,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
October 2015, ACS chemical biology,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
June 2009, Molecular vision,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
July 2001, Cancer research,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
June 2019, The journal of physical chemistry. B,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
January 2015, Genes and environment : the official journal of the Japanese Environmental Mutagen Society,
Melis Kant, and Yu-Ki Tahara, and Pawel Jaruga, and Erdem Coskun, and R Stephen Lloyd, and Eric T Kool, and Miral Dizdaroglu
November 2020, International journal of molecular sciences,
Copied contents to your clipboard!